Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

While Prevnar 13 has received FDA approval for use in adults aged 50 years and older, the CDC recommends continued use of the 23-valent polysaccharide pneumococcal vaccine until further information becomes available.

Brief Report